Thomas W. Donner, M.D.

Research

Research interests

Beta cell preservation in Type 1 diabetes
Prevention of diabetes complications

Recent publications 

• Kharlip J, Naglieri R, Mitchell B, Ryan K., Donner T. Screening for Silent Coronary Heart Disease in Type 2 Diabetes: Clinical application of American Diabetes Association guidelines. Diabetes Care 2006;29: 692-694.
  
  
• Havas  S, Donner T. Tight Control of Type 1 Diabetes: Recommendations for Patients. Am Fam Physician 2006;74:971-978.
  
  
• Donner T.  Tight Control of Hyperglycemia in Type 2 Diabetes. Insulin 2006;1:166-172.
  
  
• Donner T, Flammer K. Diabetes Management in the Hospital. Med Clin N Am  2008;92(2):407- 425.
  
  
• Lu Y, Levin G, Donner T. Tagatose, a new antidiabetic and obesity control drug.  Diabetes, Obesity and Metabolism 2008;10;109-134.
  
  
• de Boer IH, Kestenbaum B, Rue TC, Steffes MW, Cleary PA, Molitch ME, Lachin JM,  Weiss NS, Brunzell JD; for the Diabetes Control and Complications Trial  (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group.  Insulin Therapy, Hyperglycemia, and Hypertension in Type 1 Diabetes Mellitus. Arch Intern Med 2008;168(17):1867-1873.
  
  
• Fernandez-Egea E, Bernardo M, Donner T, Conget I, Parellada E, Justicia A, Esmatjes E,  Garcia-Rizo C, Kirkpatrick B. The Metabolic Profile of Antipsychotic-Naive Patients with Nonaffective Psychosis. Brit J Psych 2009;194:434-438.
  
  
•  The BARI 2D Study Group. A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease. N Engl J Med 2009;360:2503-2515.
  
  
• Shaya FT, Yan X, Lin PJ, Simoni-Wastila L, Bron M, Baran R, Donner TW. US trends in glycemic control, treatment, and comorbidity burden in patients with diabetes. J Clin Hypertens 2010;12(10):826-32. 
  
  
• Donner TW, Magder LS, Zarbalian K. Dietary supplementation with D-tagatose in subjects with type 2 diabetes leads to weight loss and raises HDL cholesterol. Nutrition Research In Press.